Functional organ preservation in laryngeal and hypopharyngeal cancer;Funktionserhaltende Therapie des Kehlkopf- und des Hypopharynxkarzinoms

Laryngo- Rhino- Otologie

Volumn 90, Issue SUPPL. 1, 2011, Pages

  Ambrosch, P ^a   Fazel, A ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

chemoradiation; hypopharyngeal cancer; laryngeal cancer; organ preservation; partial laryngectomy; transoral laser microsurgery; treatment

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; ENDOSCOPY; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MORBIDITY; ORGAN PRESERVATION; PRIORITY JOURNAL;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNGOSCOPY; LASER THERAPY; MICROSURGERY; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; VOCAL CORDS;

EID: 79955514319     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0030-1270449     Document Type: Article

References (282)

1. Stutsman AC, McGavran MH. Ultraconservative management of superficially invasive epidermoid carcinoma of the true vocal cord. Ann Otol 1971 80 507-512
2. Nassif R, Loughran S, Moyes C, MacKenzie K. Negative pathology following endoscopic resection of T1a squamous carcinoma of the glottis. J Laryngol Otol 2005 119 592-594 (Pubitemid 41113161)
3. Steiner W, Ambrosch P. Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart, New York, Georg Thieme 2000
4. Tillmann B. Atlas der Anatomie. Berlin, Heidelberg, New York, Springer 2. Auflage 2010
5. Ambrosch P, Steiner W. Komplikationen nach transoraler Lasermikrochirurgie von Mundhöhlen-, Rachen- und Kehlkopfkarzinomen. Otorhinolaryngologia Nova 1995 5 268-274 (Pubitemid 26143205)
6. Tillman B. Farbatlas der Anatomie. Zahnmedizin - Humanmedizin. Stuttgart, New York, Georg Thieme 1997
7. Ambrosch P, Brinck U, Fischer G, Steiner W. Special features of histopathological diagnosis in laser microsurgery of carcinomas of the upper aerodigestive tract. Laryngorhinootologie 1994 73 78-83 (Pubitemid 24072023)
8. Manola M, Moscillo L, Costa G, Barillari U, Lo Sito S, Mastella A, Ionna F. Conservative laser microsurgery for T1 glottic carcinoma. Auris Nasus Larynx 2008 35 141-147
9. Ambrosch P. Lasers for malignant lesions in the upper aerodigestive tract. In: Hüttenbrink KB (ed.). Lasers in Otorhinolaryngology Georg Thieme Verlag, Stuttgart 2005 113-141
10. Preuss SF, Cramer K, Drebber U, Klussmann JP, Eckel HE, Guntinas-Lichius O. Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol 2008 16 1-5
11. Sigston E, de Mones E, Babin E, Hans S, Hartl DM, Clement P, Brasnu DF. Early stage glottic cancer. Oncologic results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg 2006 132 147-152 (Pubitemid 43356250)
12. 2 laser endoscopic resection of early glottic cancer. Acta Otolaryngol 2006 126 306-310 (Pubitemid 43259237)
13. Hartl DM, de Mones E, Hans S, Janot F, Brasnu D. Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 2007 116 832-836 (Pubitemid 350174842)
14. Brondbo K, Fridrichs K, Boysen M. Laser surgery for T1 glottic carcinomas: significance of resection margins. Eur Arch Otorhinolaryngol 2007 264 627-630 (Pubitemid 46701633)
15. Remacle M, Lawson G. Results with collagen injection into the vocal folds for medialization. Curr Opin Otolaryngol Head Neck Surg 2007 15 148-152 (Pubitemid 46701349)
16. Thumfart WF, Eckel HE. Endolaryngeale Laserchirurgie zur Behandlung von Kehlkopfkarzinomen. HNO 1990 38 174-178 (Pubitemid 20204936)
17. Remacle M, Eckel HE, Antonelli A, Brasnu D, Chevalier D, Friedrich G, Olofsson J, Rudert HH, Thumfart WF, de Vincentis M, Wustrow TPU. Endoscopic cordectomy. A proposal for a classification by the working committee, European Laryngological Society. Eur Arch Otorhinolaryngol 2000 257 227-231 (Pubitemid 30259066)
18. Birchall M. EaStER - early stage glottic cancer: endoscopic excision or radiotherapy: a feasibility study. National Research Register N0212194189 (2007)
19. Coman WB, Hendrkz JK, Hickey B et al,. Laser Surgery for early glottic cancer. Head Neck Surg ANZ J Surg 2003 73 Suppl. 1 A57
20. Thomas JV, Olsen KD, Neel HB 3rd, DeSanto LW, Suman VJ. Early glottic carcinoma treated with open laryngeal procedures. Arch Otolaryngol Head Neck Surg 1994 120 264-268 (Pubitemid 24097726)
21. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck 1999 21 116-123 (Pubitemid 29096098)
22. Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR, Perez CA. Stage I (T1N0M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 1999 21 707-717
23. Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 2005 114 314-322 (Pubitemid 40529988)
24. Crampette L, Garrel R, Gardiner Q, Maurice N, Mondain M, Makeieff M, Guerrier B. Modified subtotal laryngectomy with cricohyoidoepiglottopexy - long term results in 81 patients. Head Neck 1999 21 95-103 (Pubitemid 29096095)
25. Makeieff M, de la Breteque A, Guerrier B, Giovanni A. Voice handicap evaluation after supracricoid partial laryngectomy. Laryngoscope 2009 119 746-750
26. Jacobson BH, Jonson A, Grywalski C. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 1997 6 66-70 (Pubitemid 127116315)
27. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993 14 116-121 (Pubitemid 23077346)
28. Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007 15 82-88 (Pubitemid 46594858)
29. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009 266 1333-1352
30. Ambrosch P, Rödel R, Kron M, Steiner W. Die transorale Lasermikrochirurgie des Larynxkarzinoms. Eine retrospektive Analyse von 657 Patientenverläufen. Onkologe 2001 7 505-512 (Pubitemid 32545055)
31. Mahieu H, Peeters J, Snel F, Leemans R. Transoral endoscopic surgery for early glottic cancer. Proceedings of the Fifth International Conference on Head and Neck Cancer. San Francisco, July 29-August 2. 2000 165-172
32. Eckel HE. Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome. Ann Otol Rhinol Laryngol 2001 110 7-15 (Pubitemid 32096799)
33. 2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 2002 112 370-374 (Pubitemid 34135887)
34. Pradhan SA, Pai PS, Neeli SI, D'Cruz AK. Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg 2003 129 623-625 (Pubitemid 36682896)
35. 2 laser surgery in the treatment of glottic cancer. Head Neck 2005 27 566-574
36. 2 laser treatment of early glottic carcinoma. Laryngoscope 2006 116 1007-1011 (Pubitemid 44318007)
37. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for untreated glottic carcinoma. Otolaryngol Head Neck Surg 2007 137 482-486 (Pubitemid 47320877)
38. Sjögren EV, van Rossum MA, Langeveld TPM, Voerman MS, van de Kamp VAH, Friebel MOW, Wolterbeek R, Baatenburg de Jong RJ. Voice outcome in T1a midcord glottic carcinoma. Arch Otolaryngol Head Neck Surg 2008 134 965-972
39. 2 laser treatment for Tis-T3 glottic cancer: the University of Brescia experience on 595 patients. Head Neck 2010 32 977-983
40. Eckel HE, Thumfart WF, Jungehülsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch Otorhinolaryngol 2000 257 221-226 (Pubitemid 30259065)
41. Peretti G, Piazza C, Mensi MC, Magnoni L, Bolzoni A. Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories. Ann Otol Rhinol Laryngol 2005 114 579-586 (Pubitemid 41170047)
42. Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis GA, Iro H. Comparison among different available surgical approaches in T1 glottic cancer. Laryngoscope 2009 119 1704-1708
43. Paulsen F, Tillmann B. Struktur und Funktion des ventralen Stimmlippenansatzes. Unter klinischen Gesichtspunkten. Laryngorhinootologie 1996 75 590-596 (Pubitemid 26378779)
44. Rucci L, Gammarota L, Borghi Cirri MB. Carcinoma of the anterior commissure of the larynx: I. Embryological and anatomic considerations. Ann Otol Rhinol Laryngol 1996 105 303-308 (Pubitemid 26121585)
45. Rucci L, Gammarota L, Gallo O. Carcinoma of the anterior commissure of the larynx: II. Proposal of a new staging system. Ann Otol Rhinol Laryngol 1996 105 391-396 (Pubitemid 26160653)
46. Kirchner JA, Carter D. Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol (Stockh) 1987 103 503-513 (Pubitemid 17088559)
47. Kirchner JA. What have whole organ sections contributed to the treatment of laryngeal cancer? Ann Otol Rhinol Laryngol 1989 98 661-667 (Pubitemid 19236868)
48. Hartl DM, Landry G, Hans S, Marandas P, Brasnu D. Organ preservation surgery for laryngeal squamous cell carcinoma: low incidence of thyroid cartilage invasion. Laryngoscope 2010 120 1173-1176
49. Bradley PJ, Rinaldo A, Suarez C, Shaha AR, Leemans CR, Langendijk JA, Patel SG, Ferlito A. Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol 2006 263 879-888 (Pubitemid 44386240)
50. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001 19 4029-4036 (Pubitemid 32976689)
51. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: The Christie and Royal Marsden Hospital experience. Radiother Oncol 2003 68 105-111 (Pubitemid 38367542)
52. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006 64 77-82 (Pubitemid 41831212)
53. Sjögren EV, Wiggenraad RGJ, Le Cessie S, Snijder S, Pomp J, Baatenburg de Jong RJ. Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol 2009 266 735-744
54. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol 1991 100 68-71
55. Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for early glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol 1997 18 385-390 (Pubitemid 27495802)
56. Bron L, Brossard E, Monnier P, Pasche P. Supraglottic partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope 2000 110 627-634 (Pubitemid 30198717)
57. Bron LP, Soldati D, Zouhair A, Ozsahin M, Brossard E, Monnier P, Pasche P. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 2001 23 823-829 (Pubitemid 32862285)
58. Bron L, Pasche P, Brossard E, Monnier P, Schweizer V. Functional analysis after supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Laryngoscope 2002 112 1289-1293 (Pubitemid 34747231)
59. Steiner W, Ambrosch P, Rödel RM, Kron M. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 2004 114 1485-1491 (Pubitemid 39045526)
60. Rödel RM, Steiner W, Müller RM, Kron M, Matthias C. Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 2009 31 583-592
61. Sachse F, Stoll W, Rudack C. Evaluation of treatment results with regard to initial anterior commissure involvement in early glottic carcinoma treated by external partial surgery or transoral laser microresection. Head Neck 2009 31 531-537
62. Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 2007 133 882-887 (Pubitemid 47437275)
63. Peretti G, Piazza C, Bolzoni A, Mensi MC, Rossini M, Parinello G, Shapshay SM, Antonelli A. Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 2004 113 853-858
64. Herranz J, Gavilan J, Vazquez-Barros JC. Carcinoma of the anterior commissure. Acta Otorrinolaringol Esp 2007 58 367-370 (Pubitemid 47574135)
65. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1999 43 101-106 (Pubitemid 29065838)
66. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 2000 48 723-735
67. Brouha XD, Op De Coul B, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci 2000 25 215-218 (Pubitemid 30479512)
68. Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 2002 63 257-267 (Pubitemid 34874553)
69. Jorgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx. Treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 2002 41 69-76 (Pubitemid 34293362)
70. Cho EI, Sasaki CT, Haffty BG. Prognostic significance of pre-treatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2004 58 1135-1140 (Pubitemid 38314796)
71. Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 2005 63 1378-1386 (Pubitemid 41628032)
72. Groome PA, O'Sullivan B, Mackillop WJ, Jackson LD, Schulze K, Irish JC, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SPP, Eapen LJ, Dixon PF, Bissett RJ. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 2006 64 1002-1012
73. Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, Ito J. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl 2007 557 62-65 (Pubitemid 46440548)
74. Smee RI, Meagher NS, Williams JR, Broadley K, Bridger GP. Role of radiotherapy in early glottic carcinoma. Head Neck 2010 32 850-859
75. Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010 78 461-466
76. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: Does the 2 stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 2003 55 322-328 (Pubitemid 36069089)
77. Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Biti G. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys 2005 63 1387-1394 (Pubitemid 41628033)
78. Dagan R, Morris CG, Bennett JA, Mancuso AA, Amdur RJ, Hinerman RW, Mendenhall WM. Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma. Am J Clin Oncol 2007 30 186-190 (Pubitemid 46573255)
79. Thurnher D, Erovic BM, Frommlet F, Brannath W, Ehrenberger K, Jansen B, Selzer E, Grasl MC. Challenging a dogma - Surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy. EJSO 2008 34 692-698 (Pubitemid 351671972)
80. Keilmann A, Bergler W, Artzt M, Hörmann K. Vocal function following laser and conventional surgery of small malignant vocal fold tumors. J Laryngol Otol 1996 110 1138-1141 (Pubitemid 27023465)
81. Tamura E, Kitahara S, Ogura M, Kohno N. Voice quality after laser surgery or radiotherapy for T1a glottic carcinoma. Laryngoscope 2003 113 910-914 (Pubitemid 36539169)
82. Wedman J, Heimdal JH, Elstad I, Olofsson J. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol 2002 259 547-550 (Pubitemid 35352116)
83. Verdonck-De Leeuw IM, Keus RB, Hilgers FJM, Koopmans-van Beinum FJ, Greven AJ, Jong de JMA, Vreeburg G, Bartelink H. Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance. Int J Rad Oncol Biol Phys 1999 44 1071-1078 (Pubitemid 29342909)
84. Krengli M, Policarpo M, Manfredda I, Aluffi P, Gambaro G, Panella M, Pia F. Voice quality after treatment for T1a glottic carcinoma - radiotherapy versus laser cordectomy. Acta Oncol 2004 43 284-289 (Pubitemid 38757051)
85. Nunez-Batalla F, Caminero Cueva MJ, Senaris-Gonzalez B, Llorente-Pendas JL, Gorriz-Gil C, Lopez llames A, Alonso Pantiga R, Suarez-Nieto C. Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorrhinolaryngol 2008 265 543-548
86. Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005 30 42-47 (Pubitemid 40529466)
87. Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol 2006 115 581-586 (Pubitemid 44253503)
88. Roh JL, Kim DH, Kim SY, Park C. Quality of life and voice in patients after laser cordectomy for Tis and T1 glottic carcinomas. Head Neck 2007 29 1010-1016
89. 2 laser cordectomy - what can we really expect? Head Neck 2008 30 43-49 (Pubitemid 351158320)
90. Kruse E. The role of the phoniatrician in laser surgery of the larynx. In: Steiner W, Ambrosch P: Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart, New York, Georg Thieme 2000 124-129
91. Benninger MS, Alessi D, Archer S, Bastian R, Ford C, Koufman J, Sataloff RT, Spiegel JR, Woo P. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996 115 474-482 (Pubitemid 26378553)
92. Remacle M, Lawson G, Keghian J, Jamart J. Use of injectable autologous collagen for correcting glottic gaps: initial results. J Voice 1999 13 280-288 (Pubitemid 29325944)
93. Neuenschwander MC, Sataloff RT, Abaza MM, Hawkshaw MJ, Reiter D, Spiegel JR. Management of vocal fold scar with autologous fat implantation: perceptual results. J Voice 2001 15 295-304 (Pubitemid 32525705)
94. Hirano S. Current treatment of vocal fold scarring. Curr Opin Otolaryngol Head Neck Surg 2005 13 143-147 (Pubitemid 40740916)
95. 2 laser in the diagnosis and treatment of early cancer of the vocal fold. Eur Arch Otorhinolaryngol 1997 254 169-176 (Pubitemid 27197310)
96. Arens C, Remacle M. Scarred larynx. In: Remacle M, Eckel HE (eds.). Surgery of larynx and trachea Springer, Heidelberg, Dordrecht, London, New York 2010 171-176
97. Piazza C, Bolzoni Villaret A, Redaelli De Zinis LO, Cattaneo A, Cocco D, Peretti G. Phonosurgery after endoscopic cordectomies. II. Delayed medialization techniques for major glottic incompetence after total and extended resections. Eur Arch Otorhinolaryngol 2007 264 1185-1190 (Pubitemid 350194834)
98. Sittel C, Friedrich G, Zorowka P, Eckel HE. Surgical voice rehabilitation after laser surgery for glottic carcinoma. Ann Otol Rhinol Laryngol 2002 111 493-499 (Pubitemid 34627609)
99. Rahbar R, Valdez TA, Shapshay SM. Preliminary results of intraoperative mitomycin-C in the treatment and prevention of glottic and subglottic stenosis. J Voice 2000 14 282-286 (Pubitemid 30415376)
100. Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001 110 1-6 (Pubitemid 32096798)
101. Lichtenberger G, Toohill RJ. New keel fixing technique for endoscopic repair of anterior commissure webs. Laryngoscope 1994 104 771-774 (Pubitemid 24174223)
102. Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001 110 312-317
103. Smith JC, Johnson JT, Cognetti DM, Landsittel DP, Gooding WE, Cano ER, Myers EN. Quality of life, functional outcome, and costs of early glottic cancer. Laryngoscope 2003 113 68-76 (Pubitemid 36050516)
104. 2 laser or radiotherapy for small T1a glottic carcinomas:costs, local control, survival, quality of life, and voice quality. Head Neck 2007 132 857-861
105. Yousem DM, Tufano RP. Laryngeal imaging. Neuroimaging Clin N Am 2004 14 611-624 (Pubitemid 39360999)
106. 2 laser. Acta Otolaryngol (Stockh) 1997 527 Suppl 155-159 (Pubitemid 27241773)
107. Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H, Haughey BH, Nussenbaum B, Steiner W. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007 133 1198-1204 (Pubitemid 350294247)
108. Vilaseca I, Bernal-Sprekelsen M, Luis Blanch J. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck 2010 32 929-938
109. Som ML. Cordal cancer with extension to vocal process. Laryngoscope 1975 85 1298-1307
110. Piquet JJ, Desaulty A, Pilliaert JM, Decroix G. Results of surgical treatment of cancers of the endolarynx. Acta Otorhinolaryngol Belg 1973 27 916-923
111. Lesinski SG, Bauer WC, Ogura FH. Hemilaryngectomy for T3 (fixed cord) epidermoid carcinoma of the larynx. Laryngoscope 1976 86 1563-1571
112. Biller HF, Lawson W. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord. Laryngoscope 1986 96 61-64 (Pubitemid 16183415)
113. Vega SF, Scola B, Vega MF, Martinez T, Scola E. Laryngeal vertical partial surgery. Surgical techniques. Oncological and functional results. Acta Otorhinolaryngol Ital 1996 16 272-280
114. Razack MS, Maipang T, Sako K, Bakamjian V, Shedd DP. Management of advanced glottic cancer. Am J Surg 1989 159 318-320
115. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head Neck 1994 16 406-412 (Pubitemid 24262587)
116. Bryant GP, Poulsen MG, Tripcony L, Dickie GJ. Treatment decisions in T3N0M0 glottic carcinoma. Int J Radiat Oncol Biol Phys 1995 31 285-293
117. Piquet JJ, Chevalier D. Subtotal laryngectomy with crico-hyoido- epiglotto-pexy for the treatment of extended glottic carcinoma. Am J Surg 1991 162 357-361
118. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997 106 364-369 (Pubitemid 27212879)
119. Laccourreye O, Salzer SJ, Brasnu D, Shen W, Laccourreye H, Weinstein GS. Glottic carcinoma with a fixed true vocal cord: Outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 1996 114 400-406 (Pubitemid 26097128)
120. Laccourreye O, Brasnu D, Biacabe B, Hans S, Seckin S, Weinstein G. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 1998 20 595-599 (Pubitemid 28405800)
121. Laccourreye O, Diaz EM, Muscatello L, Garcia D, Brasnu D. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis. Cancer 1999 85 40-46 (Pubitemid 29031354)
122. Laccourreye O, Laccourreye L, Muscatello L, Périé S, Weinstein G, Brasnu D. Local failure after supracricoid partial laryngectomy: symptoms, management, and outcome. Laryngoscope 1998 108 339-344 (Pubitemid 28136639)
123. Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O. Local control after supracricoid partial laryngectomy for advanced endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004 130 1092-1099 (Pubitemid 39195393)
124. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery. Head Neck Surg 1988 10 373-377 (Pubitemid 19090012)
125. Turesson I, Sandberg N, Mercke C, Johansson KA, Sandin I, Wallgren A. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns. Acta Oncol 1991 30 357-362
126. Fein DA, Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993 25 605-611 (Pubitemid 23099252)
127. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 1997 38 1001-1006 (Pubitemid 27353679)
128. Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, Hochman I, Marshak G, Sulkes A, Rakowsky E. Prognostic factors for local control of early glottic cancer: the Rabin medical center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys 1999 43 1009-1013 (Pubitemid 29144787)
129. Barthel SW, Esclamado RM. Primary radiation therapy for early glottic cancer. Otolaryngol Head Neck Surg 2001 124 35-39 (Pubitemid 32096776)
130. Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ, Stringer SP, Million RR. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989 11 123-128 (Pubitemid 20044978)
131. Mendenhall WM, Parsons JT, Mancuso AA, Pameijer FJ, Stringer SP, Cassissi NJ. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 1997 15 2394-2402 (Pubitemid 27251143)
132. Wylie JP, Sen M, Swindell R, Sykes AJ, Farrington WT, Slevin NJ. Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: influence of dose-volume parameters on outcome. Radiotherapy and Oncology 1999 53 15-21
133. Wolf GT, Hong WK, Gross Fisher S et al,. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991 324 1685-1690
134. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003 349 2091-2098 (Pubitemid 37464533)
135. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998 34 224-228 (Pubitemid 28267175)
136. Janot F, Rhein B, Koka VN, Wibault P, Domenge C, Bessede JP, Marandas P, Schwaab G, Luboinski B. Laryngeal preservation with induction chemotherapy. Experience of two GETTEC Centers, between 1985 and 1995. Ann Otolaryngol Chir Cervicofac 2002 119 12-20
137. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006 116 1-13 (Pubitemid 44337830)
138. Chen AY, Halpern M. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007 133 1270-1276 (Pubitemid 350294258)
139. Lambert L, Fortin B, Soulieres D, Guertin L, Coulombe G, Charpentier D, Tabet JC, Bélair M, Khaouam N, Nguyen-Tan PF. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? Int J Radiat Oncol Biol Phys 2010 76 398-402
140. Olsen KD. Reexamining the treatment of advanced laryngeal cancer. Editorial. Head Neck 2010 32 1-7
141. Alonso JM. Conservative surgery of cancer of the larynx. Trans Am Acad Ophthalmol Otolaryngol 1947 51 633-645
142. Labayle J, Dahan S. Reconstructive laryngectomy. Ann Otolaryngol Chir Cervicofac 1981 98 587-592 (Pubitemid 12148034)
143. 2 laser. Laboratory experiments and clinical experience. Laryngoscope 1978 88 1399-1420
144. Steiner W, Jaumann MP, Pesch HJ. Endoskopische Therapie von Krebsfrühstadien im Larynx - vorläufige Ergebnisse. Arch Otorhinolaryngol 1981 231 637-643
145. Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aerodigestive tract. Adv Otorhinolaryngol 1988 39 135-144
146. 2 laser. Laryngoscope 1983 93 429-432 (Pubitemid 13117263)
147. 2 laser excisional biopsy of early supraglottic cancer. Laryngoscope 1991 101 680-683
148. Zeitels SM, Vaughan CW, Domanowski GF. Endoscopic management of early supraglottic cancer. Ann Otol Rhinol Laryngol 1990 99 951-956
149. Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T, Martin C. Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol 2005 262 947-952 (Pubitemid 41798011)
150. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer. Arch Otolaryngol Head Neck Surg 1998 124 1245-1250
151. 2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol 2007 264 1045-1051 (Pubitemid 47106834)
152. Jäckel MC, Ambrosch P, Martin A, Steiner W. Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery. Laryngoscope 2007 117 350-357
153. Remacle M, Hantzakos A, Eckel H, Evrard AS, Bradley PJ, Chevalier D, Djukic V, de Vincentiis M, Friedrich G, Olofsson J, Peretti S, Quer M, Werner J. Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol 2009 266 993-998
154. Hirano M, Tateishi M, Kurita S, Matsuoka H. Deglutition following supraglottic horizontal laryngectomy. Ann Otol Rhinol Laryngol 1987 96 7-11 (Pubitemid 17037789)
155. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 1998 107 680-688 (Pubitemid 28371389)
156. Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 1999 108 819-827 (Pubitemid 29461192)
157. Cabanillas R, Rodrigo JP, Llorente JL, Suarez V, Ortega P, Suarez C. Functional outcomes of transoral surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 2004 26 653-659 (Pubitemid 39014629)
158. Peretti G, Piazza C, Cattaneo A, De Benedetto L, Martin E, Nicolai P. Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol 2006 115 827-832 (Pubitemid 44760492)
159. Kremer B, Schlöndorff G. Late lethal secondary hemorrhage after laser supraglottic laryngectomy. Arch Otolaryngol Head Neck Surg 2001 127 203-205 (Pubitemid 32163648)
160. Serafini I. Results of supraglottic horizontal laryngectomy. In: Wigand ME, Steiner W, Stell PM, eds.Functional Partial Laryngectomy Berlin, Heidelberg, New York Springer 1984 223-225
161. Vega MF. Early and late complications after partial resections of the larynx. In: Wigand ME, Steiner W, Stell PM, eds.Functional Partial Laryngectomy Berlin, Heidelberg, New York Springer 1984 295-298
162. Naudo P, Laccourreye O, Weinstein G, Hans S, Laccourreye H, Brasnu D. Functional outcome and prognostic factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol 1997 106 291-296 (Pubitemid 27175016)
163. Schwaab G, Kolb F, Julieron M, Janot F, Le Ridant AM, Mamelle G, Marandas P, Koka VN, Luboinski B. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997). Eur Arch Otorhinolaryngol 2001 258 246-249 (Pubitemid 32681888)
164. Joo YH, Sun DI, Cho JH, Kim MS. Factors that predict postoperative pulmonary complications after supracricoid partial laryngectomy. Arch Otolaryngol Head Neck Surg 2009 135 1154-1157
165. Decotte A, Woisard V, Percodani J, Pessey JJ, Serrano E, Vergez S. Respiratory complications after supracricoid partial laryngectomy. Eur Arch Otorhinolaryngol 2010 267 1415-1421
166. Nakfoor BM, Spiro IJ, Wang CC, Martins P, Montgomery W, Fabian R. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience. Head Neck 1998 20 379-384 (Pubitemid 28288059)
167. Sykes AJ, Slevin NJ, Gupta NK, Brewster AE. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach. Int J Radiat Oncol Biol Phys 2000 46 1109-1115 (Pubitemid 30139419)
168. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002 24 456-467 (Pubitemid 34506706)
169. Steininger JR, Parnes SM, Gardner GM. Morbidity of combined therapy for the treatment of supraglottic carcinoma: supraglottic laryngectomy and radiotherapy. Ann Otol Rhinol Laryngol 1997 106 151-158 (Pubitemid 27084009)
170. Suarez C, Rodrigo JP, Herranz J, Diaz C, Fernandez JA. Complications of supraglottic laryngectomy for carcinomas of the supraglottis and the base of the tongue. Clin Otolaryngol 1996 21 87-90 (Pubitemid 26070340)
171. Spriano G, Antognoni P, Sanguineti G, Sormani M, Richetti A, Ameli F, Piantanida R, Luraghi R, Magli A, Corvo R, Tordiglione M, Vitale V. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy. Am J Otolaryngol 2000 21 14-21
172. Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, Housset M. Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: a long-term evaluation. Otolaryngol Head Neck Surg 2000 122 752-757 (Pubitemid 30333859)
173. Bocca E, Pignataro O, Oldini C. Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol 1983 92 14-18 (Pubitemid 13157302)
174. Robbins KT, Davidson W, Peters LJ, Goepfert H. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 1988 114 421-426
175. Soo KC, Shah JP, Gopinath KS, Gerold FP, Jaques DP, Strong EW. Analysis of prognostic variables and results after supraglottic partial laryngectomy. Am J Surg 1988 156 301-305
176. DeSanto LW. Early supraglottic cancer. Ann Otol Rhinol Laryngol 1990 99 593-597
177. Lutz CK, Johnson JT, Wagner RL, Myers EN. Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol 1990 99 12-17 (Pubitemid 20043358)
178. Bocca E. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol 1991 100 261-267
179. Suarez C, Rodrigo JP, Herranz J, Llorente JL, Martinez JA. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol 1995 104 358-363
180. Herranz-Gonzales J, Gavilan J, Martinez-Vidal J, Gavilan C. Supraglottic laryngectomy: functional and oncologic results. Ann Otol Rhinol Laryngol 1996 105 18-22 (Pubitemid 26015362)
181. Martinez T, Escamilla Y, Gutierrez M, Bodoque M, Scola B, Vega MF. La cirugia parcial en el carcinoma supraglotico. Resultados oncologicos y functionales. Acta Otorrinolaringol Esp 1996 47 125-128
182. Myers EN, Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996 106 559-567 (Pubitemid 26137833)
183. Maurizi M, Paludetti G, Galli J, Ottaviani F, D'Abramo G, Almadori G. Oncological and functional outcome of conservative surgery for primary supraglottic cancer. Eur Arch Otorhinolaryngol 1999 256 283-290 (Pubitemid 29376265)
184. Bron LP, Soldati D, Monod ML, Megevand C, Brossard E, Monnier P, Pasche P. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol 2005 262 302-306 (Pubitemid 40674938)
185. Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, Lopez F, Suarez C. Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 2008 265 11-16 (Pubitemid 350160367)
186. Isaacs JH, Slattery WH III, Mendenhall WM, Cassisi NJ. Supraglottic laryngectomy. Am J Otolaryngol 1998 19 118-123 (Pubitemid 28134366)
187. Scola B, Fernandez-Vega M, Martinez T, Fernandez-Vega S, Ramirez C. Management of cancer of the supraglottis. Otorhinolaryngol Head Neck Surg 2001 124 195-198 (Pubitemid 32167809)
188. Herranz J, Martinez-Vidal J, Martinez Moran A. Supraglottic laryngectomy. Still on-going. Acta Otorrinolaryngol Esp 2006 57 235-241 (Pubitemid 47251133)
189. Laccourreye O, Brasnu D, Merite-Drancy A, Cauchois R, Chabardes E, Menard M, Laccourey H. Cricohyoidopexy in selected infrahyoid epiglottic carcinomas presenting with pathological preepiglottic space invasion. Arch Otolaryngol Head Neck Surg 1993 119 881-886 (Pubitemid 23232297)
190. Chevalier D, Piquet JJ. Subtotal laryngectomy with cricohyoidopexy for supraglottic carcinoma: review of 61 cases. Am J Surg 1994 168 472-473 (Pubitemid 24345701)
191. De Vincentiis M, Minni A, Gallo A, Di Nardo A. Supracricoid partial laryngectomies: oncologic and functional results. Head Neck 1998 20 504-509 (Pubitemid 28361454)
192. Eckel HE, Thumfart WF. Laser surgery for the treatment of larynx carcinomas: indications, techniques, and preliminary results. Ann Otol Rhinol Laryngol 1992 101 113-118
193. Zeitels SM, Koufman JA, Davis RK, Vaughan CW. Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope 1994 104 71-78 (Pubitemid 24028038)
194. Eckel HE. Endoscopic laser resection of supraglottic carcinoma. Otolaryngol Head Neck Surg 1997 117 681-687 (Pubitemid 28020734)
195. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg 2007 136 900-906 (Pubitemid 46843361)
196. Agrawal A, Moon J, Davis RK, Sakr WA, Giri SPG, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 2007 133 1044-1050 (Pubitemid 47607589)
197. 2 laser surgery for supraglottic cancer - ten years of experience. Coll Antropol 2009 33 87-91
198. 2 laser in the management of supraglottic squamous cell carcinoma. Head Neck 2009 31 1196-1206
199. Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis GA, Iro H. Evaluation of available surgical management options for early supraglottic cancer. Head Neck 2010 32 1048-1055
200. 2 laser treatment of supraglottic cancer. Head Neck 2004 26 442-446 (Pubitemid 38569203)
201. 2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol 2010 267 1735-1742
202. Harwood AR, Beale FA, Cummings BJ, Keane TJ, Payne DG, Rider WD. Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve. Arch Otolaryngol 1983 109 583-585 (Pubitemid 13049055)
203. Spaulding CS, Krochak RJ, Hahn SS, Constable WC. Radiotherapeutic management of cancer of the supraglottis. Cancer 1986 57 1292-1298 (Pubitemid 16136743)
204. Shimm DS, Coulthard SW. Radiation therapy for squamous cell carcinoma of the supraglottic larynx. Am J Clin Oncol 1989 12 17-23 (Pubitemid 19037245)
205. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery. Head Neck 1990 12 204-209 (Pubitemid 20154999)
206. Inoue Ta, Matayoshi Y, Inoue To, Ikeda H, Teshima T, Murayama S. Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer 1993 72 57-61 (Pubitemid 23182050)
207. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996 18 24-35 (Pubitemid 26002034)
208. Hafidh M, Tibbo J, Trites J, Corsten G, Hart RD, Nasser J, Wilke D, Taylor SM. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University Experience. J Otolaryngol Head Neck Surg 2009 38 434-439
209. Borgaert WVD, Ostyn F, Schueren EVD. The different clinical presentation, behavior and prognosis of carcinomas originating in the epilarynx and the lower supraglottis. Radiother Oncol 1983 1 117-131 (Pubitemid 14182311)
210. Mancuso AA, Mukherji SK, Schmalfuss I, Mendenhall W, Parsons J, Pameijer F, Hermans R, Kubilis P. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999 17 631-637 (Pubitemid 29075251)
211. Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990 18 1307-1313 (Pubitemid 20234140)
212. Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys 2002 53 948-958 (Pubitemid 34722641)
213. Beckhardt RN, Murray JG, Ford CN, Grossman JE, Brandenburg JH. Factors influencing outcome in supraglottic laryngectomy. Head Neck 1994 16 232-239 (Pubitemid 24126208)
214. Logemann JA, Gibbons P, Rademaker AW, Poulski BR, Kahrilas PJ, Bacon M, Bowman J, McCracken E. Mechanisms of recovery of swallow after supraglottic laryngectomy. J Speech Hear Res 1994 37 965-974 (Pubitemid 24307867)
215. Roh JL, Kim DH, Park CI. Voice, swallowing and quality of life in patients after transoral laser surgery for supraglottic carcinomas. J Surg Oncol 2008 98 184-189
216. Cabanillas R, Rodrigo JP, Llorente JL, Suarez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 2008 30 750-755 (Pubitemid 351913851)
217. Rademaker AW, Logemann JA, Pauloski BR, Bowman JB, Lazarus CL, Sisson GA, Milianti FJ, Graner D, Cook BS, Collin SL. Recovery of postoperative swallowing in patients undergoing partial laryngectomy. Head Neck 1993 15 325-334 (Pubitemid 23174898)
218. Schweinfurth JM, Silver SM. Patterns of swallowing after supraglottic laryngectomy. Laryngoscope 2000 110 1266-1270 (Pubitemid 30627523)
219. Lewin JS, Hutcheson KA, Barringer DA, May AH, Roberts DB, Holsinger FC, Diaz EM. Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. Head Neck 2008 30 559-566 (Pubitemid 351656096)
220. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997 107 1005-1017 (Pubitemid 27335251)
221. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The national cancer data base report on cancer of the head and neck. Arch Otolaryngol Head and Neck Surg 1998 124 951-962 (Pubitemid 28411496)
222. Garden AS, Morrison WH, Clayman GL, Ang KK, Peters LJ. Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease. Head Neck 1996 18 317-322 (Pubitemid 26177705)
223. Wang CC. Carcinoma of the hypopharynx. In: Wang CC (Ed). Radiation Therapy for Head And Neck Neoplasms John Wiley & Sons, Inc, New York, Chichester, Brisbane, Toronto, Singapore, Weinheim 1998 205-220
224. Nakamura K, Shioyama Y, Kawashima M, Saito Y, Nakamura N, Nakata K, Hareyama M, Takada T, Karasawa K, Watanabe T, Yorozu A, Tachibana H, Suzuki G, Hayabuchi N, Toba T, Yamada S. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2006 65 1045-1050
225. Yoshimura RI, Kagami Y, Ito Y, Asai M, Mayahara H, Sumi M, Itami J. Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2010 77 1017-1023
226. Chevalier RJ, Watelet JB, Darras JA, Piquet JJ. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma. Head Neck 1997 19 1-5
227. Makeieff M, Mercante G, Jouzdani E, Garrel R, Crampette L, Guerrier B. Supraglottic hemilaryngopharyngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus. Head Neck 2004 26 701-705 (Pubitemid 39014635)
228. Laccourreye O, Merite-Drancy A, Brasnu D, Chabardes E, Cauchois R, Menard M, Lacourreye H. Supracricoid hemilaryngectomy in selected pyriform sinus carcinoma staged as T2. Laryngoscope 1993 103 1379
229. Laccourreye O, Ishoo E, De Mones E, Garcia D, Kania R, Hans S. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part I: Technique, complications, and long-term functional outcome. Ann Otol Rhinol Laryngol 2005 114 25-34 (Pubitemid 40116511)
230. Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001 124 58-67 (Pubitemid 32096782)
231. Martin A, Jäckel MC, Christiansen H, Mahmoodzada M, Kron M, Steiner W. Organ preserving transoral laser microsurgery for cancer of the hypopharynx. Laryngoscope 2008 118 398-402 (Pubitemid 351640616)
232. Karatzanis AD, Psychogios G, Waldfahrer F, Zenk J, Hornung J, Velegrakis GA, Iro H. T1 and T2 Hypopharyngeal cancer treatment with laser microsurgery. J Surg Oncol 2010 102 27-33
233. Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma. Treatment results in 138 consecutively admitted patients. Acta Oncol 2000 39 529-536
234. Niibe Y, Karasawa K, Mitsuhashi T, Tanaka Y. Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survival. Jpn J Clin Oncol 2003 33 450-455 (Pubitemid 43102831)
235. Tombolini V, Santarelli M, Raffetto N, Donato V, Valeriani M, Ferretti A, Enrici RM. Radiotherapy in the treatment of stage III-IV hypopharyngeal carcinoma. Anticancer Res 2004 24 349-354 (Pubitemid 38279731)
236. Lee MS, Ho HC, Hsiao SH, Hwang JH, Lee CC, Hung SK. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer. Acta Otolaryngol 2008 28 103-109
237. Lefebvre JL, Chevalier D, Luboinski B, Traissac L, Andry G et al,. Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharyngeal SCC? Final results of the phase III EORTC 24891 trial. J Clin Oncol 2004 22 suppl 14
238. Ogura JH, Jurema DA, Watson RK. Partial laryngopharyngectomy and neck dissection for pyriform sinus cancer. Laryngoscope 1960 70 1399-1417
239. Ogura JH, Marks JE, Freemann RB. Results of conservation surgery for cancers of the supraglottis and pyriform sinus. Laryngoscope 1980 90 591-600 (Pubitemid 10131490)
240. Spector JG, Sessions DG, Emami B, Simpson J, Haughey B, Harvey J, Fredrickson JM. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results. Laryngoscope 1995 105 397-406
241. Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997 116 637-641 (Pubitemid 27355236)
242. Czaja JM, Gluckman JL. Surgical management of early-stage hypopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1997 106 909-913 (Pubitemid 27505566)
243. Laccourreye H, Lacau St Guily J, Brasnu D, Fabre A, Menard M. Supracricoid hemilaryngopharyngectomy. Analysis of 240 cases. Ann Otol Rhinol Laryngol 1987 96 217-221 (Pubitemid 17080412)
244. Foucher M, Poissonnet G, Rame JP, Toussaint B, Vedrine PO, Dassonville O, de Raucourt D, Cosmidis A. T1-T2 N0 hypopharyngeal cancers treated with surgery alone. A GETTEC study. Ann Otolaryngol Chir Cervicofac 2009 126 203-207
245. Kania R, Hans S, Garcia D, Brasnu D, De Mones E, Laccourreye O. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: Incidence and consequences of local recurrence. Ann Otol Rhinol Laryngol 2005 114 95-104 (Pubitemid 40250243)
246. Steiner W, Herbst M. Combined therapy of hypopharyngeal carcinoma consisting of endoscopic laser surgery and postoperative radiotherapy. In: Sauer R, Schwab W. (Eds.).Combined therapy of oropharyngeal and hypopharyngeal carcinoma Urban & Schwarzenberg, München, Wien, Baltimore 1987 108-113
247. Steiner W. Therapie des Hypopharynxkarzinoms. HNO 1994 42 4-13, 84-88, 104-112, 147-156, 157-165
248. Steiner W. Therapy of hypopharyngeal carcinoma. In: Johnson JT, Didolkar MS (Eds). Head and Neck Cancer Vol III. Proceedings of the Third International Conference on Head and Neck Cancer, San Francisco, 26-30 July 1992. Excerpta Medica Amsterdam, London, New York, Tokyo 1993 101-109
249. 2 laser microsurgery for hypopharyngeal carcinoma. In: Smee R, Bridger GP (Eds).Laryngeal Cancer Proceedings of the 2nd World Congress on Laryngeal Cancer, Sydney, 20-24 February 1994. Elsevier, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo 1994 606-609
250. rd European Congress of the European Federation of Oto-Rhino-Laryngological Societies EUFOS, Budapest, 9-14 June 1996. Monduzzi Editore S.p.a. Bologna 1996 669-672
251. 2 laser in the management of hypopharyngeal cancer. Current Opinion in Otolaryngology & Head and Neck Surgery 2002 10 118-122 (Pubitemid 34267532)
252. 2 laser surgery: a larynx preservation alternative for selected hypopharyngeal carcinomas. Head Neck 2004 26 953-959 (Pubitemid 39488122)
253. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Manuso AA. Parameters that predict local control following definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003 25 535-542 (Pubitemid 36736872)
254. Dirven R, Swinson BD, Gao K, Clark JR. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope 2009 119 1691-1695
255. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK, Hermans R, Kubilis PS. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 1998 20 159-169
256. Amdur RJ, Mendenhall WM, Stringer SP, Villaret DB, Cassisi NJ. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus. Head Neck 2001 23 353-362 (Pubitemid 32319482)
257. Jones AS. Tumours of the hypopharynx. In: Jones AS, Philipps DE, Hilgers FJ (Eds.). Diseases of the Head and Neck, Nose and Throat Oxford University Press, Inc, New York 1998 230-249
258. Rabbani A, Amdur RJ, Mancuso AA, Werning JW, Kirwan J, Morris CG, Mendenhall WM. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus. Int J Radiat Oncol Biol Phys 2008 72 351-355
259. Taylor SG, Murthy AK, Griem KL, Recine DC, Kiel K, Blendowski C, Hurst PB, Showel JT, Hutchinson JC Jr, Campanella RS, Chen S, Caldarelli DD. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer. 8-year analysis of results. Head Neck 1997 19 684-691 (Pubitemid 27495308)
260. Khan A, Spiro JD, Dowsett R, Greenberg BR. Sequential chemotherapy and radiotherapy for organ preservation in advanced resectable nonlaryngeal head and neck cancer. Am J Clin Oncol 1999 22 403-407 (Pubitemid 30257643)
261. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000 355 949-955 (Pubitemid 30148259)
262. Prades JM, Schmitt TM, Timoshenko AP, Simon PG, de Cornulier J, Durand M, Guillot A, Martin C. Concomitant chemoradiotherapy in pyriform sinus carcinoma. Arch Otolaryngol Head Neck Surg 2002 128 384-388 (Pubitemid 34293146)
263. Wahlberg PCG, Andersson KEH, Biörklund AT et al,. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck 1998 20 714-719 (Pubitemid 28462827)
264. Bahadur S, Thakar A, Mohanti BK, Lal P. Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 2002 116 29-32 (Pubitemid 34048885)
265. Godballe C, Jorgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002 112 834-838 (Pubitemid 34477612)
266. Chen SW, Tsai MH, Yang SN, Liang JA, Shiau AC, Lin FJ. Treatment results of hypopharyngeal cancer based on definitive radiotherapy: who is suitable for laryngeal preservation? J Laryngol Otol 2008 122 506-512
267. Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996 106 1157-1166 (Pubitemid 26304609)
268. Kotz T, Abraham S, Beitler J, Wadler S, Smith RV. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 1999 125 410-413 (Pubitemid 29169767)
269. Lazarus C, Logemann JA, Shi G, Kahrilas P, Pelzer H, Kleinjan K. Does laryngectomy improve swallowing after chemoradiotherapy? A case study. Arch Otolaryngol Head Neck Surg 2002 128 54-57 (Pubitemid 34052085)
270. Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, Butler RS, Esclamado RM. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 2006 28 808-812 (Pubitemid 44320534)
271. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery. Int J Radiat Oncol Biol Phys 1993 27 1017-1027 (Pubitemid 23361579)
272. Rodriguez J, Point D, Brunin F, Jaulerry C, Brugère J. Surgery of the hypopharynx after radiotherapy. Bull Cancer Radiother 1996 83 17-23
273. Davidson J, Keane T, Brown D, Freeman J, Gullane P, Irish J, Rotstein L, Pintilie M, Cummings B. Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997 123 420-424 (Pubitemid 27180943)
274. Clark JR, Gilbert R, Irish J, Brown D, Neligan P, Gullane P. Morbidity after flap reconstruction of hypopharyngeal defects. Laryngoscope 2006 116 173-181 (Pubitemid 44383919)
275. Taki S, Homma A, Oridate N, Suzuki S, Suzuki F, Sakashita T, Fukuda S. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 2010 267 1765-1769
276. Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a united states community standard of practice? J Clin Oncol 1997 15 2050-2055 (Pubitemid 27209536)
277. Lewin F, Damber L, Jonsson H, Andersson T, Berthelsen A, Biörklund A, Blomqvist E, Evensen JF, Hansen HS, Hansen O, Jetlund O, Mercke C, Modig H, Overgaard M, Rosengren B, Tausjö J, Ringborg U. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study. Radiother Oncol 1997 43 23-28 (Pubitemid 27191975)
278. Wolf GT, Forastiere A, Ang K, Brockstein B, Conley B, Goepfert H, Kraus D, Lefebvre JL, Pajak TF, Pfister D, Urba S. Workshop report: Organ preservation strategies in advanced head and neck cancer: current status and future directions. Head Neck 1999 21 689-1017
279. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial. J Natl Cancer Inst 1996 88 890-899 (Pubitemid 26230640)
280. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de Raucourt D, Chevalier D, Licitra L, Lunghi F, Stupp R, Lacombe D, Bogaerts J, Horiot JC, Bernier J, Vermorken JB. Phase 3 randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009 101 142-152
281. Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, Carpenter V, Miller T, Tang G, Strawderman M. Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope 2000 110 2074-2080
282. Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 2009 266 1291-1300